From January 2019, startups from nine different countries will collaborate with Merck KGaA, Darmstadt Germany Selected teams will have the opportunity to extend their stay in the company’s China Innovation Hub in Shanghai For the first time, the program includes a startup specializing in the fight against multi-drug resistant bacteria Darmstadt, Germany, January 16, 2019... Read more
Germantown, Maryland and Hilden, Germany, January 14th, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Health Canada regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic test to detect latent tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s market-leading QuantiFERON-TB technology, combining a new flexible... Read more
cobas pro integrated solutions enhances automated procedures to overcome key challenges in lab management This new Serum Work Area solution in the cobas family minimizes hands-on time and maximizes productivity through automated procedures This new innovation offers flexibility for future changing testing needs, enabling labs to further deliver quality patient care Basel, 9 Jan. 2019 Roche (SIX: RO,... Read more
Cambridge, UK, 7 January 2019: Cambridge Epigenetix Ltd, a pioneer in the development and application of epigenetic technologies, today announces its discovery and development programme for a test to detect colorectal and other cancers. This follows completion of a c. $30 million funding round, as well as the acquisition of exclusive patent rights for its... Read more
Walkersville, MD (USA) / Basel, Switzerland, 08 January 2019 – Lonza will unveil PyroTec™ PRO, the first-ever fully automated, plate-based robotic solution for endotoxin detection at SLAS2019 International Conference and Exhibition (2-6 February, Washington, DC, USA). Integrated with the latest version of Lonza’s proprietary dynamic control WinKQCL™ 6.0 Software platform, the new system has been... Read more
TORRANCE, Calif., Jan. 7, 2019 /PRNewswire/ — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation (hereinafter “Shimadzu”), in order to further expand its Healthcare Business in North America, has acquired CORE Medical Imaging, Inc. (hereinafter “CMI”). CMI, with its head office in Kenmore, WA, has successfully provided medical imaging products and service as an authorized dealer of several professional... Read more
Redwood City, California, and Hilden, Germany, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to... Read more
PDF Version SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that health officials from the National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued a recommendation that includes the use of the Prosigna® Breast Cancer Gene Signature Assay result to... Read more
19 December, 2018 bioMérieux, a world leader in the field of in vitro diagnostics, announces that its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for quality control testing of leukocyte-reduced apheresis platelet (LRAP) units with the BACT/ALERT® VIRTUO® fully automated blood culture system. This innovative FDA cleared and CE marked... Read more
By GlobeNewswire, December 31, 2018, 05:30:00 AM EDT: Source Arrayit Corporation By GlobeNewswire, December 17, 2018, 05:30:00 AM EDT: Source Arrayit Corporation Sunnyvale, Dec. 17, 2018 (GLOBE NEWSWIRE) — Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports fulfillment of a clinical instrumentation contract with the United States Food and Drug Administration (FDA),... Read more